Third article in Paolo's Biotech Notes series. PDF attached and uploaded. Additionally, Paolo has provided a relevant timely article. ContraFect Corp (CFRX) has a promising pipeline with a potential ...
Pharmaceutical Technology on MSN
How biotech executives are confronting the funding and regulatory shifts
Amidst regulatory turmoil and a funding resurgence, companies provide insights on how they are navigating the changing ...
Welcome to another edition of Core Biotech!I started this portfolio with the objective of proving that Long-Term investing in the biotech sector is a worthwhile endeavor.New buys and sells are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results